Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpresaria Group Regulatory News (EMR)

Share Price Information for Empresaria Group (EMR)

Share Price is delayed by 15 minutes
Get Live Data
22.50    0.00 (0.00%)
Bid:
21.00
Ask:
24.00
Spread: 3.00 (14.286%)
Market Cap: £11.04m
EMR Live PriceLast checked at - London Stock Exchange

Intraday Empresaria Group Share Chart

Form 8.3 - Empresaria Group plc

21 Aug 2025 12:02

RNS Number : 2988W
TrinityBridge Limited
21 August 2025
 

FORM 8.3

 

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

TrinityBridge Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Empresaria Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

20/08/2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

5p ORDINARY

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

3,584,973

7.19

 

 

(2) Cash-settled derivatives:

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

TOTAL:

3,584,973

7.19

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

GB00B0358N07

Purchase

969

£ 0.41

GB00B0358N07

Sale

969

£ 0.41

GB00B0358N07

Sale

9,344

£ 0.4015

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

N/A

 

N/A

N/A

N/A

N/A

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

 

N/A

N/A

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

21/08/2025

Contact name:

Laura Whittam

Telephone number:

+44 (0) 20 8036 8612

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETPPUPURUPAGGG
Date   Source Headline
12th May 20217:00 amRNSTransaction in Own Shares
11th May 20217:00 amRNSTransaction in Own Shares
6th May 20217:00 amRNSSenior Leadership Appointments
4th May 20217:00 amRNSTransaction in Own Shares
29th Apr 20217:00 amRNSTransaction in Own Shares
28th Apr 20217:00 amRNSTransaction in Own Shares
23rd Apr 20217:00 amRNSTransaction in Own Shares
13th Apr 20217:00 amRNSAnnual Report and Accounts and Notice of AGM
12th Apr 202112:28 pmRNSHolding(s) in Company
7th Apr 20217:00 amRNSTransaction in Own Shares
26th Mar 20212:54 pmRNSDirector/PDMR Shareholding
19th Mar 20217:00 amRNSTransaction in Own Shares
18th Mar 20217:00 amRNSFinal Results
2nd Mar 20217:00 amRNSInvestor Meet Company Presentation
22nd Feb 20212:19 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSTrading Update and Notice of Results
22nd Dec 20201:18 pmRNSTransaction in Own Shares & Total Voting Rights
18th Dec 20209:41 amRNSTransaction in Own Shares
2nd Dec 20207:55 amRNSTransaction in Own Shares
2nd Dec 20207:00 amRNSTrading Update
12th Nov 20207:00 amRNSTransaction in Own Shares
5th Nov 20207:00 amRNSTransaction in Own Shares
29th Oct 20201:38 pmRNSHolding(s) in Company
7th Oct 202010:02 amRNSTransaction in Own Shares
6th Oct 20207:00 amRNSTransaction in Own Shares
25th Sep 20202:56 pmRNSTransaction in Own Shares
22nd Sep 20207:00 amRNSTransaction in Own Shares
9th Sep 20205:39 pmRNSTransaction in Own Shares
8th Sep 20203:15 pmRNSDirector / PDMR Shareholding
18th Aug 20207:00 amRNSTransaction in Own Shares
12th Aug 20207:00 amRNSInterim Results
10th Aug 20207:00 amRNSInvestor Meet Company presentation
31st Jul 20207:00 amRNSRevision: Trading Update and Notice of Results
22nd Jul 20207:00 amRNSTrading Update and Notice of Results
1st Jul 20203:36 pmRNSTransaction in Own Shares
30th Jun 202012:40 pmRNSTransaction in Own Shares
25th Jun 20208:54 amRNSTransaction in Own Shares
17th Jun 20205:18 pmRNSShare Buyback Programme
27th May 20201:04 pmRNSDirector/PDMR Shareholding
26th May 20201:23 pmRNSResult of AGM
26th May 20207:00 amRNSTrading update, acq. of non-controlling interest
8th Apr 20207:00 amRNSTrading and COVID-19 Update and Notice of AGM
30th Mar 20204:32 pmRNSAwards pursuant to the Company's LTIP
20th Mar 202012:08 pmRNSDirector/PDMR Shareholding
18th Mar 20201:10 pmRNSDirector Dealing
18th Mar 20207:00 amRNSFinal Results
6th Mar 20207:00 amRNSChange of Nominated Adviser and Broker
5th Feb 20202:53 pmRNSHolding(s) in Company
29th Jan 20207:00 amRNSTrading Update and Notice of Results
3rd Dec 201910:36 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.